• LAST PRICE
    6.3100
  • TODAY'S CHANGE (%)
    Trending Up0.2600 (4.2975%)
  • Bid / Lots
    6.3000/ 4
  • Ask / Lots
    6.3100/ 13
  • Open / Previous Close
    6.1900 / 6.0500
  • Day Range
    Low 6.1350
    High 6.7700
  • 52 Week Range
    Low 4.3050
    High 20.1200
  • Volume
    1,203,917
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 6.05
TimeVolumeVERV
09:32 ET309486.2
09:33 ET423396.3009
09:35 ET107646.29
09:37 ET137726.27
09:39 ET13096.3
09:42 ET41396.28
09:44 ET20126.27
09:46 ET60186.255
09:48 ET160436.19
09:50 ET32946.238
09:51 ET37026.19
09:53 ET50906.2
09:55 ET52846.19
09:57 ET42296.2385
10:00 ET112906.2601
10:02 ET2006.23
10:04 ET17176.265
10:06 ET65486.31
10:08 ET21176.26
10:09 ET17826.27
10:11 ET102066.285
10:13 ET60986.28
10:15 ET14346.295
10:18 ET40476.32
10:20 ET31006.29
10:22 ET108256.28
10:24 ET18136.275
10:26 ET27116.25
10:27 ET67806.215
10:29 ET87976.23
10:31 ET30186.24
10:33 ET6406.21
10:36 ET20506.2
10:38 ET59576.19
10:40 ET40546.185
10:42 ET5736.18
10:44 ET38606.24
10:45 ET31976.27
10:47 ET99356.315
10:49 ET8246.31
10:51 ET31966.32
10:54 ET22486.33
10:56 ET63776.33
10:58 ET32006.2901
11:00 ET8686.315
11:02 ET19786.335
11:03 ET36896.325
11:05 ET56536.36
11:07 ET92966.41
11:09 ET28266.4
11:12 ET38216.425
11:14 ET151546.5388
11:16 ET41506.55
11:18 ET48836.6
11:20 ET22286.61
11:21 ET77376.5953
11:23 ET67136.6012
11:25 ET100106.69
11:27 ET109306.715
11:30 ET64056.715
11:32 ET68916.655
11:34 ET34786.705
11:36 ET62586.665
11:38 ET30856.7
11:39 ET45446.71
11:41 ET51186.745
11:43 ET103976.7088
11:45 ET54596.74
11:48 ET105046.695
11:50 ET37006.695
11:52 ET37206.73
11:54 ET192286.755
11:56 ET74886.755
11:57 ET39506.72
11:59 ET60006.6904
12:01 ET47946.65
12:03 ET33296.61
12:06 ET106456.6
12:08 ET3006.61
12:10 ET174256.535
12:12 ET44846.495
12:14 ET53956.475
12:15 ET25756.465
12:17 ET36926.46
12:19 ET46146.425
12:21 ET21836.455
12:24 ET18666.464
12:26 ET9876.45
12:28 ET4576.445
12:30 ET15006.45
12:32 ET5346.465
12:33 ET114976.52
12:35 ET24006.525
12:37 ET14756.535
12:39 ET19016.56
12:42 ET34436.55
12:44 ET7006.545
12:46 ET10656.54
12:48 ET7136.54
12:50 ET2006.535
12:51 ET3006.535
12:53 ET24556.535
12:55 ET12436.56
12:57 ET7656.525
01:00 ET29606.54
01:02 ET8226.52
01:04 ET2176.52
01:06 ET17006.51
01:08 ET52996.495
01:09 ET18026.505
01:11 ET8006.51
01:13 ET29886.47
01:15 ET51906.44
01:18 ET18626.465
01:20 ET64006.475
01:22 ET448406.425
01:24 ET38136.41
01:26 ET18416.415
01:27 ET209966.45
01:29 ET52706.435
01:31 ET33836.425
01:33 ET41336.43
01:36 ET67996.45
01:38 ET23506.465
01:40 ET33066.46
01:42 ET66206.56
01:44 ET65256.55
01:45 ET58626.54
01:47 ET308196.41
01:49 ET17006.425
01:51 ET10006.445
01:54 ET96466.38
01:56 ET44006.4
01:58 ET7006.425
02:00 ET55426.385
02:02 ET9576.39
02:03 ET6006.43
02:05 ET7886.42
02:07 ET9006.405
02:09 ET2756.41
02:12 ET21956.42
02:14 ET4006.41
02:18 ET14836.415
02:20 ET27786.41
02:21 ET54906.41
02:23 ET9006.39
02:25 ET8326.405
02:27 ET7006.41
02:30 ET2006.39
02:32 ET15336.4
02:34 ET2006.405
02:36 ET15006.4
02:38 ET16326.4
02:39 ET4006.4
02:41 ET4076.4
02:43 ET8006.4
02:45 ET34026.38
02:48 ET12266.39
02:50 ET1006.39
02:52 ET9986.39
02:54 ET35786.3936
02:56 ET15146.38
02:57 ET75136.3
02:59 ET38906.285
03:01 ET267046.33
03:03 ET22006.3001
03:06 ET13006.31
03:08 ET70106.31
03:10 ET70546.34
03:12 ET40016.35
03:14 ET35056.335
03:15 ET46836.36
03:17 ET18006.34
03:19 ET67406.3501
03:21 ET47956.36
03:24 ET36366.365
03:26 ET50936.355
03:28 ET27266.36
03:30 ET177726.3
03:32 ET47606.2911
03:33 ET135126.31
03:35 ET99386.35
03:37 ET95206.36
03:39 ET148326.335
03:42 ET84116.32
03:44 ET41006.31
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVERV
Verve Therapeutics Inc
512.0M
-2.4x
---
United StatesKZR
Kezar Life Sciences Inc
517.3M
-0.5x
---
United StatesMGTX
MeiraGTx Holdings PLC
460.0M
-4.1x
---
United StatesPRTC
PureTech Health PLC
495.1M
-7.0x
---
United StatesAURA
Aura Biosciences Inc
504.5M
-5.7x
---
United StatesKALV
Kalvista Pharmaceuticals Inc
502.6M
-3.2x
---
As of 2024-11-05

Company Information

Verve Therapeutics, Inc. is a clinical-stage genetic medicines company. The Company is focused on developing a new approach to the care of cardiovascular disease (CVD), transforming treatment from chronic management to single-course gene editing medicines. The Company’s lead programs include VERVE-101, VERVE-102, and VERVE-201, which target genes that have been validated as targets for lowering low-density lipoprotein cholesterol (LDL-C), a root cause of atherosclerotic cardiovascular disease (ASCVD). VERVE-101 and VERVE-102 are designed to permanently turn off the PCSK9 gene in the liver and are being developed initially for heterozygous familial hypercholesterolemia (HeFH). VERVE-201 is designed to permanently turn off the ANGPTL3 gene in the liver and is initially being developed for homozygous familial hypercholesterolemia (HoFH) and for refractory hypercholesterolemia where patients still have high LDL-C despite treatment with maximally tolerated standard of care therapies.

Contact Information

Headquarters
201 Brookline Avenue, Suite 601BOSTON, MA, United States 02215
Phone
978-501-3026
Fax
302-655-5049

Executives

Independent Chairman of the Board
Burt Adelman
President, Chief Operating Officer, General Counsel
Andrew Ashe
Chief Executive Officer, Director
Sekar Kathiresan
Chief Financial Officer
Allison Dorval
Chief Administrative Officer
Joan Nickerson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$512.0M
Revenue (TTM)
$20.6M
Shares Outstanding
84.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.75
EPS
$-2.59
Book Value
$7.31
P/E Ratio
-2.4x
Price/Sales (TTM)
24.8
Price/Cash Flow (TTM)
---
Operating Margin
-1,075.00%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.